Increased international requirements and FDA cuts

被引：0

|

作者：

Immel, Barbara K. ^{[1
]}

机构：

[1] Immel Resources LLC, Petahma, CA 94952 USA

来源：

BIOPHARM INTERNATIONAL | 2007年 / 20卷 / 02期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：34 / +

页数：2

相关论文

共 50 条

[1] Requirements for FDA Approval
Basu, Sankar
PROCEEDINGS OF LIGHT-ACTIVATED TISSUE REGENERATION AND THERAPY CONFERENCE, 2008, 12 : 269 - 269
[2] International aid cuts
Megget, Katrina
CHEMISTRY & INDUSTRY, 2021, 85 (7-8) : 16 - 16
[3] US FDA cuts time to get drugs to market
不详
EUROPEAN CHEMICAL NEWS, 1996, 65 (1709): : 4 - 4
[4] GMP/FDA requirements to aseptic production
Langer, U
Mangel, A
PHARMAZEUTISCHE INDUSTRIE, 2002, 64 (04): : 375 - 383
[5] FDA's NEPA requirements to continue
Paper Recycler, 1997, 8 (07):
[6] The FDA revises requirements for levothyroxine products
Burman, Kenneth
Hennessey, James
McDermott, Michael
Wartofsky, Leonard
Emerson, Charles
THYROID, 2008, 18 (05) : 487 - 490
[7] FDA Revamps Biosimilar Quality Requirements
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2019, 32 (07) : 6 - 7
[8] FDA cGMP Requirements for PET Drugs
Norenberg, Jeffrey P.
Schwarz, Sally
VanBrocklin, Henry
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (05) : 16N - 16N
[9] FDA revamps biosimilar quality requirements
Wechsler, Jill
Pharmaceutical Technology, 2019, 43 (07) : 14 - 15
[10] CURRENT STATUS OF FDA TOXICITY REQUIREMENTS
FANCHER, OE
CALANDRA, JC
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 153 (A1) : 258 - &

← 1 2 3 4 5 →